mk2 Biotechnologies
Konstantinos Antonopoulos is an accomplished professional with extensive experience in leadership and technology within the biotechnology and automotive sectors. Currently serving as CEO at mk2 Biotechnologies since September 2018, Konstantinos oversees overall strategy, business development, branding, communication, and legal matters. Prior to this role, Konstantinos was a TechScout and R&D Project Manager focused on battery cell technology at BMW Group from February 2013 to September 2018, and conducted doctoral research in chemistry at the Technical University of Munich. Additional experience includes a diploma student position at Siemens and a COO role at PushUp Vitamine OHG. Konstantinos holds a Dr. rer. nat. in Chemistry and a Diplom-Physik in Physics from the Technical University of Munich.
This person is not in any teams
mk2 Biotechnologies
mk2 Biotechnologies develops, produces and investigates peptides & proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications.